European equities are often viewed through a narrow macro lens, driven primarily by euro-area growth expectations. However, this perspective understates their true potential. Today’s European equity market represents a diversified, innovation-driven and globally connected opportunity set, offering investors access to high-quality companies with competitive advantages, attractive valuations and long-term structural growth drivers.
Europe: a global innovation hub
Contrary to common misconceptions, Europe is not an innovation laggard. It is home to a dense cluster of high-performing innovation economies. In the 2025 Global Innovation Index, 16 European countries ranked among the top 25 globally, underscoring strong research ecosystems, skilled talent pools and a track record of producing globally competitive businesses.
This innovation extends beyond early-stage disruptors into large, established companies across sectors such as healthcare, technology and industrials. Leading firms such as ASML and AstraZeneca demonstrate that investors can access world-class innovators in Europe.
Attractive valuations and diversification benefits
European equities offer a compelling combination of lower market concentration, more attractive valuations and broad sector exposure compared to US equities. The MSCI Europe Index is not dominated by a handful of mega-cap companies, providing investors with diversified sources of return potential.